| Document |
Document Title |
|
WO/2014/048953A1 |
The invention concerns a kit for preventing or treating oxidative stress in humans or animals by means of therapeutically active hydrogen molecules. The hydrogen molecules are formed by reacting a base metal with aqueous acids or bases a...
|
|
WO/2014/045561A1 |
The present invention addresses the problems of providing an anticancer drug comprising a carotenoid and of providing a novel carotenoid and an antioxidant comprising the novel carotenoid. The above problems are solved by the discovery t...
|
|
WO/2014/040590A1 |
The invention relates to the use of a humic acid preparation RB4 or lignocellulose carbon isolate for treating diseases in warm-blooded animals caused by a plant protection agent glyphosate, wherein the plant protection agent glyphosate ...
|
|
WO/2014/039712A1 |
Patient reported outcome (PRO) instruments are useful for collecting information from celiac disease patients, patients with gluten intolerance or gluten sensitivity, and patients on gluten free diets.
|
|
WO/2014/039917A1 |
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...
|
|
WO/2014/037412A1 |
The invention relates to compositions and methods for improving memory and related functions as alertness, attention, concentration, learning, and language processing. More particularly, the invention relates to compositions comprising a...
|
|
WO/2014/037927A1 |
The present application relates to the use of chlorate for treating subjects who have been exposed to radiation. More particularly, the application relates to the use of chlorate for treating subjects with acute radiation syndrome. The a...
|
|
WO/2014/039862A1 |
Methods of modulating, adjusting, and maintenance of the glutathione redox status of an individual, or cell, tissues, bodily fluids, or body compartments of the individual, are disclosed, as are compositions suitable for such modulating,...
|
|
WO/2014/036821A1 |
Disclosed are a novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as a preparation method and a use thereof. The compound is a ternary conjugate formed by combining a thrombolytic peptide...
|
|
WO/2014/032375A1 |
Disclosed are a lactobacillus plantarum having function of cadmium expelling and the use thereof. The lactobacillus plantarum CCFM8610 of the present invention has acid resistance and good ability of resisting and adsorbing cadmium ions ...
|
|
WO/2014/024984A1 |
The purpose of the present invention is to provide a hydrogen mixed gas supply device capable of administering a mixed gas having the hydrogen gas concentration and the oxygen gas concentration thereof each appropriately adjusted in acco...
|
|
WO/2014/020219A1 |
The present invention relates to a method for obtaining a product of Myrciaria dubia fruit with a ripeness level 20 % - 30 %, removing the seeds from the selected fruits and drying the seedless fruits at a temperature of less than 60 ºC...
|
|
WO/2014/017046A1 |
The present invention addresses the problem of providing a prophylactic and/or therapeutic agent for radiation damage, which has a novel mechanism of action, can prevent and alleviate a wide variety of conditions of radiation damage for ...
|
|
WO/2014/008648A1 |
A composition comprising reduced glutathione and acetaminophen and preparation method thereof. The main drug of the composition is 0.1%-99.9% reduced glutathione, 99.9%-1% acetaminophen. The composition can be formulated as tablets, sust...
|
|
WO/2014/010656A1 |
Provided is a blood alcohol concentration reduction accelerating agent which rapidly improves various unpleasant symptoms caused after alcohol consumption such as bloating, nausea and hangover. The blood alcohol concentration reduction a...
|
|
WO/2014/003808A1 |
The method of extracting kaempferol-based antioxidants from Solenostemma arghel provides a method of producing medicinal antioxidants for usage as anti-inflammatory and analgesic treatments. The kaempferol-based antioxidants are primaril...
|
|
WO/2013/187391A1 |
The present invention relates to a combination of a sesamin compound, γ-orizanol and a rice germ oil.
|
|
WO/2013/179308A3 |
The invention relates to a composition with anti-hyperglycemic, antidiabetic and antioxidant activity obtained from the extract of parts of coconut tree selected from roots, bark, trunk, leaves and coconut shell and husk or combinations ...
|
|
WO/2013/172714A1 |
We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligo...
|
|
WO/2013/169740A2 |
Synthetic triterpenoids and methods of using the same to induce gene expression and differentiation of stem or progenitor cells are provided.
|
|
WO/2013/155720A1 |
A fatigue relief and health care capsule, the capsule being prepared from ganoderma lucidum extract, pseudostellaria root extract, codonopsis pilosula extract, wolfberry fruit extract, and hericium erinaceus extract.
|
|
WO/2013/155717A1 |
Provided is a body building capsule, comprising Ganoderma lucidum extract, Radix Panacis Quinquefolii extract, milkvetch root extract, Hericium erinaceus extract and Paecilomyces hepialid mycelium.
|
|
WO/2013/149333A1 |
The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.
|
|
WO/2013/152055A1 |
Radiation - oxidative exposure treatment compositions comprise a mixture of micronutrient multivitamin and trace elements, a mixture of antioxidants and chemopreventative agents, and optionally a mixture of fatty acids. Micronutrient mul...
|
|
WO/2013/148183A2 |
|
|
WO/2013/143322A1 |
The present invention relates to the technical field of medicine, and relates specifically to a method for dissolving a flavonoid compound, a carbon glycoside compound, or a stilbene compound and a method for preparing an injection or a ...
|
|
WO/2013/147439A1 |
The present invention relates to a systemic immunity or gut immunity adjuvant comprising ethanol-soluble cheonggukjang extracts as active ingredients. The immunity adjuvant comprising ethanol-soluble cheonggukjang extracts according to t...
|
|
WO/2013/141759A3 |
The invention relates to medicine, specifically to neurology and cardiology, namely to the production of a drug in the form of a biologically active nanopreparation having antihypoxic and antioxidant activity. The use of liposomal con...
|
|
WO/2013/142258A1 |
The present disclosure is directed to compositions comprising encapsulated particles of diethylenetriaminepentaacetate (DTPA) and a zinc salt such as zinc acetate, and to pharmaceutical compositions comprising such encapsulated compositi...
|
|
WO/2013/137777A1 |
The invention relates to the field of the pharmaceutical industry and medicine. The problem addressed by the present invention is that of producing an effective pharmaceutical composition having neuroprotector, antiamnesic, antioxidan...
|
|
WO/2013/137844A1 |
A method for isolating flavonoid Dihydroquercetin (taxifolin) from wood parts including lower portions of the trunk, referred to as butt logs, bark and roots. The method includes extracting either the particle-reduced chip fraction obtai...
|
|
WO/2013/137854A1 |
Antibodies and antibody fragments that selectively bind to nanoparticles are provided herein.
|
|
WO/2013/137778A1 |
The invention relates to the field of the pharmaceutical industry and medicine, and can be used in the production and use of solid dosage forms having neuroprotector, antiamnesic, antioxidant, antihypoxic and antiischaemic activity. T...
|
|
WO/2013/127146A1 |
Provided is a Lactobacillus plantarum able to relieve lead toxicity and the use thereof. The Lactobacillus plantarum is Lactobacillus plantarum CCFM8661, which has good acid tolerance and good tolerance to lead ions in vitro. The Lactoba...
|
|
WO/2013/129977A3 |
The invention relates to the field of the pharmaceutical industry and medicine. The problem of the invention consists in producing a pharmaceutical composition having neuroprotector, antiamnaesic, antioxidant, antihypoxic and antiischaem...
|
|
WO/2013/129960A1 |
The invention relates to the field of medicine and concerns a pharmaceutical composition in which the treatment effect is produced as a result of the action of the antioxidant, antimicrobial and antitoxic human lactoferrin protein and wh...
|
|
WO/2013/125135A1 |
Provided is an anthocyanin-containing composition which enhances the bioabsorbability of anthocyanins, which have low bioavailability, causes anthocyanins to be more effectively absorbed in vivo, and enhances absorption of anthocyanins i...
|
|
WO/2013/123618A1 |
A process for the manufacture of an extract of the skin of Goji berries containing zeaxanthin and/or its esters, comprises the following steps: a) obtaining dried skin of Goji berries or the size reduced pieces thereof; and b) extracting...
|
|
WO/2013/120379A1 |
Provided in the present invention is the use of SBT in the preparation of an inhibitor of GSK-3β, and in particular in the preparation of medicines for preventing and treating Alzheimer's disease and senescence.
|
|
WO/2013/122501A1 |
The invention concerns a pharmaceutical composition for the treatment of acute toxic conditions and relates to the field of medicine, more particularly nanotechnology and toxicology, and can be used for the prevention and treatment of to...
|
|
WO/2013/120081A1 |
The present disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such...
|
|
WO/2013/111801A1 |
Provided is a triblock copolymer represented by general formula (I): CNR-PEG-CNR (wherein CNR's independently represent a polymer segment that contains a repeating unit containing, as a part of a pendant group, a cyclic nitroxide radical...
|
|
WO/2013/108822A1 |
Provided are food and drink, a non-medicinal product, and a medicine in which high antioxidant effect is exhibited over a long period of time in vivo. Des(rhamnosyl) acteoside is added to an olive extract, whereby high antioxidant activi...
|
|
WO/2013/107236A1 |
Disclosed is a crystal form of (6S)-5- methyltetrahydrofolate salt and a method for preparing same. The crystal form is: C form of the crystal form of (6S)-5- methyltetrahydrofolate calcium salt, the X-ray diffraction pattern thereof hav...
|
|
WO/2013/106683A1 |
The present disclosure provides methods of treating and/or preventing cancer in a subject comprising administering to the subject a copper-reduced diet by itself or as a supplement along with a regular diet to create a copper-reduced mel...
|
|
WO/2013/097274A1 |
An active small-molecule donkey-hide gelatin mixture and a preparation method and application thereof. The active small-molecule donkey-hide gelatin mixture is prepared by using the compound protease comprising the proline protease to pe...
|
|
WO/2013/099883A1 |
Disclosed are: a lactic acid bacterium which has a higher IgA production promoting activity than that of Lactobacillus strain GG (ATCC53103) and a lower mitogenic activity and a lower IL-2 production promoting activity than those of List...
|
|
WO/2013/083552A1 |
The invention describes diphenylhydramine (DPH) for treating ototoxicity in a subject, for inhibiting the formation of platinum adducts in a cell of the inner ear, and for preventing and/or inhibiting structural and functional damage in ...
|
|
WO/2013/079394A1 |
The present invention generally relates to the field of nutrition, health and wellness. For example, the present invention relates to hydroxycinnamic acids and their health benefits. The present invention discloses compositions that allo...
|
|
WO/2013/075391A1 |
Disclosed are an electromagnetic therapeutic apparatus and a supporting physiotherapy liquid thereof, wherein upper magnetic heads (13) are mounted on the frame of the electromagnetic therapeutic apparatus via a bearing and lower magneti...
|
